News
Silence Therapeutics plc, a global clinical-stage company developing novel siRNA (short interfering RNA) therapies, presented additional data showcasing the SANRECO phase 1 study of divesiran in ...
EMA’s veterinary medicinal products committee recommends marketing authorization to Elanco’s Zenrelia to treat atopic dermatitis in dogs: Greenfield, Indiana Monday, June 16, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback